C. Robert Horsburgh

Active 1982–2025

133
Papers
19,166
Citations
78
h-index
120
i10-index

Citations

Citations per year for C. Robert Horsburgh1983: 14 citations1984: 16 citations1985: 3 citations1986: 8 citations1987: 8 citations1988: 8 citations1989: 13 citations1990: 18 citations1991: 24 citations1992: 47 citations1993: 52 citations1994: 67 citations1995: 63 citations1996: 59 citations1997: 58 citations1998: 52 citations1999: 63 citations2000: 59 citations2001: 65 citations2002: 57 citations2003: 48 citations2004: 73 citations2005: 83 citations2006: 74 citations2007: 74 citations2008: 66 citations2009: 70 citations2010: 81 citations2011: 62 citations2012: 75 citations2013: 77 citations2014: 98 citations2015: 74 citations2016: 106 citations2017: 114 citations2018: 114 citations2019: 380 citations2020: 423 citations2021: 365 citations2022: 325 citations2023: 219 citations2024: 432 citations2025: 193 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,801 citing papers, 24.4% of this breakdownUnited Kingdom: 626 citing papers, 8.5% of this breakdownSouth Africa: 437 citing papers, 5.9% of this breakdownChina: 330 citing papers, 4.5% of this breakdownIndia: 264 citing papers, 3.6% of this breakdownAustralia: 259 citing papers, 3.5% of this breakdownCanada: 228 citing papers, 3.1% of this breakdownSwitzerland: 214 citing papers, 2.9% of this breakdownGermany: 207 citing papers, 2.8% of this breakdownItaly: 205 citing papers, 2.8% of this breakdownFrance: 203 citing papers, 2.8% of this breakdownNetherlands: 198 citing papers, 2.7% of this breakdown
0%24.4%Other 32.5%

Fields

  • Medicine82.9%
  • Immunology and Microbiology5.3%
  • Biochemistry, Genetics and Molecular Biology3.8%
  • Health Professions1.5%
  • Social Sciences1%
  • Environmental Science0.8%
  • Other4.7%

Topics

  • Tuberculosis Research and Epidemiology22%
  • Mycobacterium research and diagnosis9.1%
  • Infectious Diseases and Tuberculosis5.9%
  • Diagnosis and treatment of tuberculosis5.7%
  • Pneumocystis jirovecii pneumonia detection and treatment5.1%
  • Pneumonia and Respiratory Infections3%
  • Other49.2%

Coauthors

All papers

Open in search
  1. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng Chen, Jitendra Singh, Li‐Min Huang, Surendra K. Sharma, Djohar Hannoun, Helena del Corral, Anna M. Mandalakas, LaShaunda L. Malone, Du-Lin Ling, Afrânio Lineu Kritski, Catherine M. Stein, Richa Vashishtha, F Boulahbal, Chi‐Tai Fang, W. Henry Boom, Eduardo Martins Netto, Antônio Carlos Moreira Lemos, Anneke C. Hesseling, Alexander Kay, Edward C. Jones‐López, C. Robert Horsburgh, Christoph Lange, Jason R. Andrews - The Lancet Global Health 2022 cited by 202

  2. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey R. Starke, John Wilson, Jonathan M. Wortham, Terence Chorba, Barbara Seaworth - American Journal of Respiratory and Critical Care Medicine 2019 cited by 453

  3. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2020 cited by 486

  4. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gavin Churchyard, Dick Menzies, Anneke C. Hesseling, Eric Nuermberger, Helen McIlleron, Kevin P. Fennelly, Eric Goemaere, Ernesto Jaramillo, Marcus Low, Carolina Morán Jara, Nesri Padayatchi, Robin M. Warren - The Lancet Respiratory Medicine 2017 cited by 679

  5. Multidrug-resistant tuberculosis

    Authors: , , , , , , , , , , , - Nature Reviews Disease Primers 2024 cited by 205

  6. Management of drug-resistant tuberculosis

    Authors: , , , , , - The Lancet 2019 cited by 301

  7. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carlton A. Evans, Chi‐Tai Fang, Katherine Fielding, Greg J. Fox, Luis F. Garcı́a, Alberto L. García‐Basteiro, Steffen Geis, Stephen M. Graham, Louis Grandjean, Djohar Hannoun, Mark Hatherill, Anja M. Hauri, Anneke C. Hesseling, Philip C. Hill, Li‐Min Huang, Helena Huerga, Rabia Hussain, Leah G. Jarlsberg, Edward C. Jones‐López, Seiya Kato, Midori Kato‐Maeda, Beate Kampmann, H. Lester Kirchner, Afrânio Lineu Kritski, Christoph Lange, Chih‐Hsin Lee, Li‐Na Lee, Meng‐Rui Lee, Antônio Carlos Moreira Lemos, Christian Lienhardt, Du-Lin Ling, Qiao Liu, Nathan C. Lo, Richard Long, Elisa López‐Varela, Peng Lü, Matthew J. Magee, LaShaunda L. Malone, Anna M. Mandalakas, Neil Martinson, Rufaida Mazahir, Megan Murray, Eduardo Martins Netto, Larissa Otero, Julie Parsonnet, Arthur Reingold, H. Simon Schaaf, James A. Seddon, Surendra K. Sharma, Jitendra Singh, Sarman Singh, Rosa Sloot, Giovanni Sotgiu, Catherine M. Stein, Najeeha Talat Iqbal, Rina Triasih, Lisa Trieu, Maarten F. Schim van der Loeff, Patrick Van der Stuyft, Cari van Schalkwyk, Richa Vashishtha, Lilly M. Verhagen, Julian A. Villalba, Jann‐Yuan Wang, Christopher C. Whalen, Takashi Yoshiyama, Heather J. Zar, Jean-Pierre Zellweger, Limei Zhu - The Lancet 2020 cited by 350

  8. Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 983

  9. Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asker Ismayilov, Ernesto Jaramillo, Sandra V. Kik, Katharina Kranzer, Christian Lienhardt, Philip LoBue, Knut Lönnroth, Guy B. Marks, Dick Menzies, Giovanni Battista Migliori, Davide Mosca, Ya Diul Mukadi, Alwyn Mwinga, Lisa Nelson, Nobuyuki Nishikiori, Anouk Oordt-Speets, Molebogeng X. Rangaka, Andreas Reis, Lisa D. Rotz, Andreas Sandgren, Monica Sañé Schepisi, Holger J. Schünemann, Surender K. Sharma, Giovanni Sotgiu, Helen R. Stagg, Timothy R. Sterling, Tamara Tayeb, Mukund Uplekar, Marieke J. van der Werf, Wim Vandevelde, Femke van Kessel, Anna van't Hoog, Jay K. Varma, Natalia Vezhnina, Constantia Voniatis, Marije Vonk Noordegraaf‐Schouten, Diana Weil, Karin Weyer, Robert J. Wilkinson, Takashi Yoshiyama, J.-P. Zellweger, Mario Raviǵlione - European Respiratory Journal 2015 cited by 591

  10. Recent advances in the treatment of tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2023 cited by 116

  11. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2022 cited by 73

  12. Treatment of Tuberculosis

    Authors: , , - New England Journal of Medicine 2015 cited by 327

  13. Global, regional, and national estimates of tuberculosis incidence and case detection among incarcerated individuals from 2000 to 2019: a systematic analysis

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Public Health 2023 cited by 70

  14. Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis

    Authors: , , , , , - Clinical Infectious Diseases 2012 cited by 378

  15. Undernutrition and Tuberculosis: Public Health Implications

    Authors: , , , , , , , - The Journal of Infectious Diseases 2018 cited by 199

  16. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emmanuelle Cambau, Dumitru Chesov, Francesca Conradie, Vivian Cox, Keertan Dheda, Andrii Dudnyk, Maha Farhat, Sébastien Gagneux, Martin P. Grobusch, Matthias I. Gröschel, Lorenzo Guglielmetti, Irina Kontsevaya, Berit Lange, Frank van Leth, Christian Lienhardt, Anna M. Mandalakas, Florian P. Maurer, Matthias Merker, Paolo Miotto, Bárbara Molina-Moya, F. Morel, Stefan Niemann, Nicolas Véziris, Andrew Whitelaw, C. Robert Horsburgh, Christoph Lange, C. Robert Horsburgh, Christoph Lange - The Lancet Infectious Diseases 2023 cited by 85

  17. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2002 cited by 411

  18. Nutritional Supplementation Would Be Cost-Effective for Reducing Tuberculosis Incidence and Mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) Model

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 38

  19. DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial

    Authors: , , , , , , , , , , , , , , , , - Vaccine 2020 cited by 72

  20. Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Neus Altet, Seiya Kato, Chi‐Tai Fang, Steffen Geis, Anja M. Hauri, Richard Long, Claudia C. Dobler, Joan A. Caylà, Tsira Chakhaia, Cheng Chen, Alberto L. García‐Basteiro, Rina Triasih, Li‐Min Huang, Surendra K. Sharma, Djohar Hannoun, LaShaunda L. Malone, Du-Lin Ling, Afrânio Lineu Kritski, Catherine M. Stein, Amyn A. Malik, Orvalho Augusto, Richa Vashishtha, F Boulahbal, W. Henry Boom, Ye Shen, Anneke C. Hesseling, C. Robert Horsburgh, Christoph Lange, Anna M. Mandalakas, Christoph Lange, Anna M. Mandalakas - The Lancet Respiratory Medicine 2024 cited by 44

  21. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Lange, Payam Nahid, Bernard Fourie, Norbert Ndjeka, Andrew Nunn, Giovanni Battista Migliori, Zarir Udwadia, C. Robert Horsburgh, Gavin Churchyard, Dick Menzies, Anneke C. Hesseling, James A. Seddon, Marcus Low, Salmaan Keshavjee, Eric Nuermberger, Helen McIlleron, Kevin P. Fennelly, Amina Jindani, Ernesto Jaramillo, Nesri Padayatchi, Clifton E. Barry, Robin M. Warren - The Lancet Respiratory Medicine 2019 cited by 118

  22. Evaluation of exposure-specific risks from two independent samples: A simulation study

    Authors: , , , - BMC Medical Research Methodology 2011 cited by 311

  23. Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup

    Authors: , , , , - American Journal of Epidemiology 2013 cited by 213

  24. A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex

    Authors: , , , , , , , - Clinical Infectious Diseases 1999 cited by 142